Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement

Journal of Gynecologic Oncology
Dong Hoon SuhDuk Soo Bae

Abstract

Since after 2006 when the first edition of practice guidelines for gynecologic oncologic cancer treatment was released, the Korean Society of Gynecologic Oncology (KSGO) has published the following editions on a regular basis to suggest the best possible standard care considering updated scientific evidence as well as medical environment including insurance coverage. The Guidelines Revision Committee was summoned to revise the second edition of KSGO practice guidelines, which was published in July 2010, and develop the third edition. The current guidelines cover strategies for diagnosis and treatment of primary and recurrent ovarian cancer. In this edition, we introduced an advanced format based on evidence-based medicine, collecting up-to-date data mainly from MEDLINE, EMBASE, and Cochrane Library CENTRAL, and conducting a meta-analysis with systematic review. Eight key questions were raised by the committee members. For every key question, recommendations were developed by the consensus meetings and provided with evidence level and strength of the recommendation.

References

Feb 11, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M MarkmanW Hoskins
Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P G RoseH D Homesley
Feb 22, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G ZanettaC Mangioni
Mar 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V DierasP Pouillart
Mar 16, 2004·Journal of Pediatric Surgery·D BillmireUNKNOWN Children's Oncology Group (COG)
May 30, 2006·Hematology/oncology Clinics of North America·Kristin A Bradley, Daniel G Petereit
Sep 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jacobus PfistererUNKNOWN EORTC GCG
Feb 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lari B WenzelUNKNOWN Gynecologic Oncology Group
Jul 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David G MutchAngeles Alvarez Secord
Nov 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert A BurgerJoel I Sorosky
Feb 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gabriella FerrandinaGiovanni Scambia
Apr 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David S MillerCecelia H Boardman
Sep 8, 2010·The New England Journal of Medicine·Ignace VergoteUNKNOWN NCIC Clinical Trials Group
Oct 2, 2012·The Oncologist·Daniela FischerovaDavid Cibula
Dec 13, 2012·Obstetrics and Gynecology·Janice S KwonC Blake Gilks
Nov 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bella KaufmanSusan M Domchek
Jan 30, 2015·Journal of the National Cancer Institute·Henrik FalconerDaniel Altman
Mar 5, 2016·The New England Journal of Medicine·John K ChanBradley J Monk
Apr 23, 2016·Journal of Gynecologic Oncology·Min Chul ChoiUNKNOWN Korean Society of Gynecologic Oncology
May 10, 2016·Obstetrics and Gynecology·Jason D WrightDawn L Hershman
Feb 23, 2018·Journal of Gynecologic Oncology·Dong Hoon SuhJae Weon Kim

❮ Previous
Next ❯

Methods Mentioned

BETA
lavage
biopsy
biopsies
scraping
dissection
hysterectomy
pancreatectomy
X-ray
surgical resection

Software Mentioned

Cochrane Library CENRAL

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.